澳大利亚住院老年人护理中的抗胆固醇药物使用和跌倒:一项后期多站点队列研究
Ying Xu1, Magdalena Z Raban2, Ling Li2
1Center for Health Systems and Safety Research, Faculty of Medicine, Health and Human Sciences, Australian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Road, North Ryde, Sydney, NSW, 2109, Australia. ying.xu@mq.edu.au.
在老年护理人员中,抗胆固醇负荷较高与跌倒风险增加有关. 抗胆剂可以帮助新入住者预防跌倒.
科学领域:
- 老年学
- 药理学
- 流行病学
背景情况:
- 对于老年护理机构的住户来说, 跌倒是一个很大的风险.
- 这种人群中抗胆固醇药物负担与下降之间的关系尚不清楚.
研究的目的:
- 研究抗胆固醇负荷与老年护理机构新入住者中跌倒的发生率之间的关系.
- 在居住的第一年评估这种联系.
主要方法:
- 使用来自澳大利亚新南威尔士州27个老年护理机构的数据.
- 包括2300名65岁及以上的新入住者,在入住后被跟踪了一年.
- 使用了六种不同的抗胆固醇负担量表和混合效应的后勤回归模型,调整了混因素.
主要成果:
- 在第一年观察到抗胆固醇负荷的持续增加.
- 抗胆固醇负荷增加与较高的跌倒风险显著相关,几率比率在不同尺度上从1. 08到1. 18不等.
- 所有六个评估的抗胆固醇量表都显示出与跌倒风险的积极关联.
结论:
- 抗胆固醇负担是新老年护理人员倒的重要危险因素.
- 这些研究结果表明,抗胆固醇评估尺度可以成为制定有针对性的防摔策略的有价值工具.
- 早期识别和管理抗胆固醇负载可以提高老年护理机构的住宿安全性.
更多相关视频
04:13Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
06:52Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Cholinergic Antagonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Therapeutic Uses
